The latest announcements, research milestones, and practice updates from Elman Retina Group. Our physicians are at the forefront of retinal care innovation.
Moshe Horowitz and Dr. Michael J. Elman presented landmark research at the 2026 ARVO Annual Meeting in Denver, exploring the association between post-injection corneal abrasions and dry eye disease.
A recent multicenter study co-authored by Dr. Schechet published in Frontiers in Ophthalmology explores how gastrointestinal and liver conditions can lead to vision-threatening vitamin A deficiency.
Elman Retina Group is pleased to announce that Dr. Daniel Brill, M.D., dual-fellowship trained in vitreoretinal surgery and uveitis, is now accepting new patients at our Baltimore-area offices.
Dr. Dao co-authored an extensive review in Advances in Ophthalmology and Optometry detailing the complex indications, surgical techniques, and outcomes of vitreoretinal surgery for patients with uveitis.
Dr. Elman served as the national Study Chairman of the DRCRnet Protocol I clinical trial, a pivotal study published in the New England Journal of Medicine that transformed the standard of care for diabetic macular edema.
Dr. Schechet's published research in the journal RETINA and contributions to Ryan's Retina textbook advance our understanding of optical coherence tomography and vitreoretinal surgical techniques.
Dr. Dao's published research in the journal Cells explores how diet and the gut microbiome influence retinal health — an emerging area of science that could lead to new strategies for preventing vision loss.
Dr. Brill co-authored a multicenter clinical study published in the journal RETINA examining patterns of ocular inflammation — advancing our understanding of how the immune system can affect the eyes.
Elman Retina Group expanded with a new office location in Catonsville to better serve patients in the Baltimore metropolitan area.
The Elman Retina Group has announced the availability of Encelto, the first FDA-approved therapy for Macular Telangiectasia Type 2 (MacTel). This cutting-edge encapsulated cell therapy provides contin…
Dr. Michael J. Elman presented cutting-edge research findings on advanced retinal therapeutics at the prestigious Macula Society annual meeting.
Dr. Sidney Schechet joined the "Open Your Eyes" podcast to discuss advances in diabetic retinopathy treatment and the importance of regular eye screenings.
As one of the top clinical trial sites in the Mid-Atlantic region, Elman Retina Group gives patients access to cutting-edge treatments before they're widely available.
Dr. Elman and Dr. Schechet were part of a cutting-edge wet AMD research study to validate the usability and visualization performance of the new first-of-its-kind Home OCT system leading to FDA marketing authorization.
Michael J. Elman, M.D. presented trial results at the 48th Annual Meeting of the Macula Society.
Dr. Schechet explored the connection between overall health and peak performance as you age on the Open Your Eyes Radio Show with Dr. Kerry Gelb.
Elman Retina Group presented 'Wizard of the Eyes' at the Foundation Fighting Blindness VisionWalk 2024.
Dr. Elman reached over 7,700 citations, positioning him among the top 5% of researchers on Doximity.
A sub-analysis of the ALOFT study showed how remote monitoring can generate aggregates of large data sets and provide unique insights on the predictive nature of non-exudative ForeseeHome alerts.
Six eyes in six patients with dialysis-associated retinal detachments were successfully repaired with one pneumatic retinopexy procedure.
Dr. Elman was voted #1 in the Vision Care section of the 2021 Baltimore Jewish Times' "Best of Jewish Baltimore" competition.
Dr. Schechet and his team published new research regarding macular hole closure with medical treatment.
Dr. Schechet published research showing high rates of musculoskeletal disorders among practicing ophthalmologists — important for prevention through proper ergonomics.
Dr. Elman presented results on the Clinical Utility of Home OCT Data in Management of Neovascular Age Related Macular Degeneration at the 47th annual meeting of the Macula Society in Palm Springs, California.
A new technology impacting surgical technique, management, and decision-making. Published by Dr. Schechet, Dr. Elman, and colleagues in Retinal Physician.
Dr. Elman visited the world-famous Ophthalmology Department at the University of Paris, Créteil, learning ground-breaking methods for analyzing OCT angiograms to aid in early diagnosis of macular diseases.
Dr. Elman served as moderator at the diabetes session and presented results on visual field changes among eyes with proliferative diabetic retinopathy on behalf of the DRCR Retina Network.
Our physicians also write in-depth articles to help patients understand their conditions and treatment options.
View All Blog Articles →For the latest updates on retinal care and practice news, follow Elman Retina Group or schedule a consultation.
📞 410-686-3000